Newly Activated Clinical Trials

This is a listing of clinical trials recently activated by the University of Illinois Cancer Center Clinical Trials Office for patient enrollment. Click the study links below to learn details regarding the studies on clinicaltrials.gov. You can also search for other clinical trials on our website. For more information or questions about a study, email [email protected] or call 312-355-5112.

---

Protocol Title: ANBL2131:  A Phase 3 Study of Dinutuximab Added to Intensive Multimodal Therapy for Children with Newly Diagnosed High-Risk Neuroblastoma

Protocol Title: ALTE2321: Walking Juntos: Developing and Testing a Culturally-Tailored Mobile Health and Social Media Physical Activity Intervention Among Adolescent and Young Adult Childhood Cancer Survivors

Sponsors: Children’s Oncology Group

Principal Investigator: Dipti Dighe, MD

---

Protocol Title: AMC-107: A Phase 2 Trial of Ixazomib for Kaposi Sarcoma

Sponsor: AIDS Malignancy Consortium (AMC)

Principal Investigator: Paul Rubinstein, MD

---